Last updated: February 18, 2021
Sponsor: Vanderbilt University Medical Center
Overall Status: Completed
Phase
4
Condition
Hair Loss
Warts
Scleroderma
Treatment
N/AClinical Study ID
NCT03630198
181119
Ages > 12 All Genders Accepts Healthy Volunteers
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- >12 years old presenting with an indication for intralesional steroid injection
Exclusion
Exclusion Criteria:
- Unconsentable
- Not a candidate for corticosteroid injection
- Contraindication to lidocaine
Study Design
Total Participants: 31
Study Start date:
October 01, 2018
Estimated Completion Date:
September 01, 2019
Connect with a study center
Vanderbilt University Medical Center
Nashville, Tennessee 37235
United StatesSite Not Available
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.